Caricamento...
Early erythropoiesis‐stimulating agents in preterm or low birth weight infants
BACKGROUND: Preterm infants have low plasma levels of erythropoietin (EPO), providing a rationale for the use of erythropoiesis‐stimulating agents (ESAs) to prevent or treat anaemia and to provide neuro protection and protection against necrotising enterocolitis (NEC). Darbepoetin (Darbe) and EPO ar...
Salvato in:
| Pubblicato in: | Cochrane Database Syst Rev |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
John Wiley & Sons, Ltd
2020
|
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7014351/ https://ncbi.nlm.nih.gov/pubmed/32048730 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD004863.pub6 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|